Putnam Investments LLC Sarepta Therapeutics, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $3.52 Million - $4.25 Million	-34,388 Reduced 62.84%	20,332 $2.46 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $2.97 Million - $4.39 Million	-27,930 Reduced 33.79%	54,720 $6.27 Million
Q1 2023 May 22, 2023	SELL	$117.53 - $155.99 $2.9 Million - $3.85 Million	-24,668 Reduced 22.99%	82,650 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $706 - $924	-7 Reduced 0.01%	107,318 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $3.84 Million - $6.05 Million	50,725 Added 89.62%	107,325 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $3.55 Million - $5.01 Million	56,600 New	56,600 $4.24 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $2.79 Million - $6.51 Million	-38,560 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $141,757 - $201,797	-1,129 Reduced 2.84%	38,560 $6.57 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $3.68 Million - $4.99 Million	-28,957 Reduced 42.18%	39,689 $5.57 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $4.73 Million - $8.73 Million	-50,854 Reduced 42.56%	68,646 $11 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $3.39 Million - $5.42 Million	41,200 Added 52.62%	119,500 $11.7 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $5.99 Million - $10.6 Million	78,300 New	78,300 $10.1 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $2.14 Million - $4.62 Million	-29,438 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $106,936 - $144,808	-953 Reduced 3.14%	29,438 $4.47 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $295,369 - $420,001	-2,769 Reduced 8.35%	30,391 $3.62 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $2.11 Million - $2.96 Million	18,312 Added 123.33%	33,160 $5.36 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $644,512 - $1.38 Million	-8,984 Reduced 37.7%	14,848 $1.96 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $59,422 - $90,497	1,100 Added 4.84%	23,832 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $255,255 - $304,066	5,358 Added 30.84%	22,732 $1.26 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $620,773 - $819,184	17,374	17,374 $788,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account